26 Rue d'Ulm
75005 Paris

Tél. : 01 44 32 40 00 (Paris)
Tél.: 01 47 11 15 15 (Saint-Cloud)

Note HAS (French High Authority of Health)
Certification of the centre
by HAS - French High Authority of Health
Satisfaction and feedback
of the patient Overall score
of hospitalized patients
Satisfaction and feedback
of the patient Overall score
of patients admitted for outpatient surgery

Institut Curie, leading French cancer centre, combines an internationally-renowned research centre and state-of-the-art hospital treating all types of cancer, including the rarest types. Founded in 1909 by Marie Curie, Institut Curie brings together 3,700 researchers, doctors and nursing staff on 3 sites (Paris, Saint-Cloud and Orsay) to carry out 3 missions: treatment, research and teaching. As a foundation recognised as promoting the public interest and authorised to receive donations, Institut Curie can fast-track discoveries thanks to the support of its patrons.


The mission of the Institut Curie’s research centre is to understand the complex workings of living things. The fundamental research developed there makes it possible to implement sophisticated translational research, an incalculable source of innovations rising to the scientific, technological and medical challenges posed by cancer. Its scientific advances range from the normal or cancerous cell to the whole body, opening the way to new knowledge in order to promote the development of new therapeutic areas, essential to the fight against cancer. The research centre houses 86 multidisciplinary teams and provides them with 18 state-of-the-art technology platforms. Thanks to its unique model which ensures the continuum between fundamental, translational and clinical research, it facilitates the transformation of findings into medical applications, so patients can benefit from diagnostic and therapeutic innovations at the earliest possible opportunity.


The hospital treats a wide range of cancers: breast cancer, paediatric cancer, respiratory system cancer, gynaecological cancer, gastrointestinal cancer, male genital cancer, blood and bone marrow cancer, head and neck cancer, skin cancer, urinary system cancer, thyroid cancer, central nervous system cancer and eye tumours and sarcoma. It places the best skills and sophisticated techniques at the service of global and continuous management of each individual patient, as part of a permanently multidisciplinary approach, at all stages of the disease and with a constant concern for patient quality-of-life. Birthplace of radiotherapy, pioneer in conservative treatments and the development of supportive care, it continues to innovate in complex therapeutic techniques and pathways (high-precision radiotherapy, proton therapy, photon therapy, precision medicine, imaging, oncoplasty, oncogenetics and more). With a high clinical research capacity, Institut Curie sponsors many clinical trials and includes its patients in them whenever possible.

Preservation and transmission of knowledge

Teaching and training future doctors, nursing staff and researchers are a priority at Institut Curie. Each year more than 500 PhD students, interns, masters students and student nurses come from the 4 corners of the world to finish their studies on courses at Institut Curie. By participating in the dissemination of knowledge, Institut Curie helps improve the treatment of patients worldwide and to further our understanding of living things.

Number of beds and places
3 713
Number of employees
10 998
Number of patients treated every year

Types of cancer treated

Cancers digestifs
Cancers hématologiques
Cancers de l’appareil génital masculin
Cancers urologiques
Tumeurs du système nerveux central
Cancer du poumon
Autres tumeurs thoraciques
Cancers de la sphère ORL
Cancer de la thyroïde et parathyroïde
Cancer du sein
Cancers gynécologiques
Tumeurs cutanées
Cancers oculaires
Cancers pédiatriques, des adolescents et jeunes adultes
Tumeurs rares


Thérapies ciblées
Radiologie interventionnelle
Car-T cells
Soins de support

Training courses

  • DIU (Diplômes Inter Universitaires) :
    Oncogénétique (Université de Paris, Université Paris 13)
    Médecine Moléculaire en Cancérologie (Université de Paris, Université Paris Sud)
    Diagnostic et Prise en Charge des Sarcomes et Tumeurs Mésenchymateuses (Université de Paris, Université de Marseille, Université de Bordeaux, Université de Lyon, Université de Strasbourg, Université de Lille) ;
    Européen d’Oncologie Gynécologique et Mammaire (Université de Paris, Université de Nantes et Université de Lyon)
    DU (Diplôme Universitaire) :
  • Pathologie Mammaire (Université Versailles Saint Quentin – Paris Saclay)
    Oncologie Oculaire (Université de Paris)
    Diplôme d’études spécialisées complémentaires (DESC) de cancérologie
    Cours internationaux et accueil de médecins internationaux
    Pour toutes informations utiles sur les formations et l’enseignement délivrés par le Centre de recherche

Labels of the centre

Centre's social networks